相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Insulin resistance drives hepatic de novo lipogenesis in nonalcoholic fatty liver disease
Gordon Smith et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
Ketone Bodies Are Mildly Elevated in Subjects with Type 2 Diabetes Mellitus and Are Inversely Associated with Insulin Resistance as Measured by the Lipoprotein Insulin Resistance Index
Erwin Garcia et al.
JOURNAL OF CLINICAL MEDICINE (2020)
Deficiency of 3-hydroxybutyrate dehydrogenase (BDH1) in mice causes low ketone body levels and fatty liver during fasting
Hiroki Otsuka et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2020)
The regulation of hepatic fatty acid synthesis and partitioning: the effect of nutritional state
Leanne Hodson et al.
NATURE REVIEWS ENDOCRINOLOGY (2019)
NAFLD and Diabetes: Two Sides of the Same Coin? Rationale for Gene-Based Personalized NAFLD Treatment
Ming-Feng Xia et al.
FRONTIERS IN PHARMACOLOGY (2019)
Non-alcoholic fatty liver disease - A global public health perspective
Zobair M. Younossi
JOURNAL OF HEPATOLOGY (2019)
Role of ketone signaling in the hepatic response to fasting
Caroline E. Geisler et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2019)
Impaired ketogenesis and increased acetyl-CoA oxidation promote hyperglycemia in human fatty liver
Justin A. Fletcher et al.
JCI INSIGHT (2019)
NAFLD/NASH in patients with type 2 diabetes and related treatment options
M. G. Radaelli et al.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2018)
Myeloid-specific Acat1 ablation attenuates inflammatory responses in macrophages, improves insulin sensitivity, and suppresses diet-induced obesity
Li-Hao Huang et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2018)
Role of DGAT enzymes in triacylglycerol metabolism
Bhumika Bhatt-Wessel et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2018)
NAFLD and diabetes mellitus
Herbert Tilg et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2017)
HMGCS2 is a key ketogenic enzyme potentially involved in type 1 diabetes with high cardiovascular risk
Sanket Kumar Shukla et al.
SCIENTIFIC REPORTS (2017)
Mechanisms of Insulin Resistance in Primary and Secondary Nonalcoholic Fatty Liver
Tomas Jelenik et al.
DIABETES (2017)
Multi-dimensional Roles of Ketone Bodies in Fuel Metabolism, Signaling, and Therapeutics
Patrycja Puchalska et al.
CELL METABOLISM (2017)
De novo lipogenesis in the liver in health and disease: more than just a shunting yard for glucose
Francis W. B. Sanders et al.
BIOLOGICAL REVIEWS (2016)
Screening diabetic patients for non-alcoholic fatty liver disease with controlled attenuation parameter and liver stiffness measurements: a prospective cohort study
Raymond Kwok et al.
GUT (2016)
Presence of diabetes mellitus and steatosis is associated with liver stiffness in a general population: The Rotterdam study
Edith M. Koehler et al.
HEPATOLOGY (2016)
Pathophysiology and Mechanisms of Nonalcoholic Fatty Liver Disease
Joel T. Haas et al.
ANNUAL REVIEW OF PHYSIOLOGY, VOL 78 (2016)
Liver-Specific Silencing of Lipin1 Reduces Fat Mass as Well as Hepatic Triglyceride Biosynthesis in Mice
Kazuaki Kajimoto et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2016)
Metabolic Impact of Nonalcoholic Steatohepatitis in Obese Patients With Type 2 Diabetes
Romina Lomonaco et al.
DIABETES CARE (2016)
Hepatocyte-Specific Disruption of CD36 Attenuates Fatty Liver and Improves Insulin Sensitivity in HFD-Fed Mice
Camella G. Wilson et al.
ENDOCRINOLOGY (2016)
Global Epidemiology of Nonalcoholic Fatty Liver Disease: Meta-Analytic Assessment of Prevalence, Incidence, and Outcomes
A. Lonardo et al.
HEPATOLOGY (2016)
Nonalcoholic fatty liver disease is associated with an almost twofold increased risk of incident type 2 diabetes and metabolic syndrome. Evidence from a systematic review and meta-analysis
Stefano Ballestri et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2016)
Clinical assessment of hepatic de novo lipogenesis in non-alcoholic fatty liver disease
Sabina Paglialunga et al.
LIPIDS IN HEALTH AND DISEASE (2016)
Molecular mechanisms of lipotoxicity and glucotoxicity in nonalcoholic fatty liver disease
Manoela Mota et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2016)
Non-alcoholic fatty liver disease and diabetes
Jonathan M. Hazlehurst et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2016)
Recent insights on the role of cholesterol in non-alcoholic fatty liver disease
Graciela Arguello et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2015)
Effect of a high-fat diet on the hepatic expression of nuclear receptors and their target genes: relevance to drug disposition
Ragia H. Ghoneim et al.
BRITISH JOURNAL OF NUTRITION (2015)
Hepatic Acetyl CoA Links Adipose Tissue Inflammation to Hepatic Insulin Resistance and Type 2 Diabetes
Rachel J. Perry et al.
CELL (2015)
Adaptation of Hepatic Mitochondrial Function in Humans with Non-Alcoholic Fatty Liver Is Lost in Steatohepatitis
Chrysi Koliaki et al.
CELL METABOLISM (2015)
High Prevalence of Nonalcoholic Fatty Liver Disease in Patients With Type 2 Diabetes Mellitus and Normal Plasma Aminotransferase Levels
Paola Portillo-Sanchez et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2015)
Transcriptional regulation of hepatic lipogenesis
Yuhui Wang et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2015)
Perinatal deiodinase 2 expression in hepatocytes defines epigenetic susceptibility to liver steatosis and obesity
Tatiana L. Fonseca et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Type 2 diabetes mellitus
Ralph A. DeFronzo et al.
NATURE REVIEWS DISEASE PRIMERS (2015)
Diabetes mellitus: The epidemic of the century
Akram T. Kharroubi et al.
WORLD JOURNAL OF DIABETES (2015)
Increased De Novo Lipogenesis Is a Distinct Characteristic of Individuals With Nonalcoholic Fatty Liver Disease
Jennifer E. Lambert et al.
GASTROENTEROLOGY (2014)
Extrahepatic Complications of Nonalcoholic Fatty Liver Disease
Matthew J. Armstrong et al.
HEPATOLOGY (2014)
Prevalence of Type 1 and Type 2 Diabetes Among Children and Adolescents From 2001 to 2009
Dana Dabelea et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)
Ketogenesis prevents diet-induced fatty liver injury and hyperglycemia
David G. Cotter et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Definition, epidemiology, and classification of diabetes in children and adolescents
Maria E. Craig et al.
PEDIATRIC DIABETES (2014)
Ketone bodies as signaling metabolites
John C. Newman et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2014)
Ketosis Onset Type 2 Diabetes Had Better Islet beta-Cell Function and More Serious Insulin Resistance
Hongyun Lu et al.
JOURNAL OF DIABETES RESEARCH (2014)
Liver Aminotransferases and Risk of Incident Type 2 Diabetes: A Systematic Review and Meta-Analysis
Setor K. Kunutsor et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2013)
Decreased Transcription of ChREBP-α/β Isoforms in Abdominal Subcutaneous Adipose Tissue of Obese Adolescents With Prediabetes or Early Type 2 Diabetes Associations With Insulin Resistance and Hyperglycemia
Romy Kursawe et al.
DIABETES (2013)
Inhibition of Class I Histone Deacetylases Unveils a Mitochondrial Signature and Enhances Oxidative Metabolism in Skeletal Muscle and Adipose Tissue
Andrea Galmozzi et al.
DIABETES (2013)
Mechanisms of hepatic triglyceride accumulation in non-alcoholic fatty liver disease
Yuki Kawano et al.
JOURNAL OF GASTROENTEROLOGY (2013)
Nonalcoholic fatty liver disease: molecular pathways and therapeutic strategies
Yue Ye Huang et al.
LIPIDS IN HEALTH AND DISEASE (2013)
The global NAFLD epidemic
Rohit Loomba et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2013)
Suppression of Oxidative Stress by β-Hydroxybutyrate, an Endogenous Histone Deacetylase Inhibitor
Tadahiro Shimazu et al.
SCIENCE (2013)
De novo lipogenesis in human fat and liver is linked to ChREBP-β and metabolic health
Leah Eissing et al.
NATURE COMMUNICATIONS (2013)
The origin of circulating CD36 in type 2 diabetes
M. J. Alkhatatbeh et al.
NUTRITION & DIABETES (2013)
The Impact of Hyperglycemic Emergencies on the Kidney and Liver
Feng Bai et al.
JOURNAL OF DIABETES RESEARCH (2013)
Altered Hepatic Lipid Metabolism Contributes to Nonalcoholic Fatty Liver Disease in Leptin-Deficient Ob/Ob Mice
James W. Perfield et al.
JOURNAL OF OBESITY (2013)
Low-carbohydrate ketogenic diets, glucose homeostasis, and nonalcoholic fatty liver disease
Rebecca C. Schugar et al.
CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE (2012)
Effect of adipose tissue insulin resistance on metabolic parameters and liver histology in obese patients with nonalcoholic fatty liver disease
Romina Lomonaco et al.
HEPATOLOGY (2012)
Increased risk of hepatocellular carcinoma in patients with diabetes mellitus: A systematic review and meta-analysis of cohort studies
Chenggang Wang et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Long-Term Administration of the Histone Deacetylase Inhibitor Vorinostat Attenuates Renal Injury in Experimental Diabetes through an Endothelial Nitric Oxide Synthase-Dependent Mechanism
Andrew Advani et al.
AMERICAN JOURNAL OF PATHOLOGY (2011)
Hepatic steatosis, inflammation, and ER stress in mice maintained long term on a very low-carbohydrate ketogenic diet
Joel R. Garbow et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2011)
Class IIa Histone Deacetylases Are Hormone-Activated Regulators of FOXO and Mammalian Glucose Homeostasis
Maria M. Mihaylova et al.
CELL (2011)
Excessive Hepatic Mitochondrial TCA Cycle and Gluconeogenesis in Humans with Nonalcoholic Fatty Liver Disease
Nishanth E. Sunny et al.
CELL METABOLISM (2011)
Selective Reversible Inhibition of Liver Carnitine Palmitoyl-Transferase 1 by Teglicar Reduces Gluconeogenesis and Improves Glucose Homeostasis
Roberto Conti et al.
DIABETES (2011)
Combined Effect of Nonalcoholic Fatty Liver Disease and Impaired Fasting Glucose on the Development of Type 2 Diabetes A 4-year retrospective longitudinal study
Ji Cheol Bae et al.
DIABETES CARE (2011)
Lipid in the livers of adolescents with nonalcoholic steatohepatitis: combined effects of pathways on steatosis
Lixin Zhu et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2011)
Nonalcoholic Fatty Liver Disease: Focus on Lipoprotein and Lipid Deregulation
Klementina Fon Tacer et al.
JOURNAL OF LIPIDS (2011)
Hdac3 Is Essential for the Maintenance of Chromatin Structure and Genome Stability
Srividya Bhaskara et al.
CANCER CELL (2010)
Oxidative Stress and Diabetic Complications
Ferdinando Giacco et al.
CIRCULATION RESEARCH (2010)
Population-based risk factors and resource utilization for HCC: US perspective
A. Sanyal et al.
CURRENT MEDICAL RESEARCH AND OPINION (2010)
Hepatic steatosis: a role for de novo lipogenesis and the transcription factor SREBP-1c
P. Ferre et al.
DIABETES OBESITY & METABOLISM (2010)
Fatty Acid Metabolism in the Liver, Measured by Positron Emission Tomography, Is Increased in Obese Individuals
Patricia Iozzo et al.
GASTROENTEROLOGY (2010)
Molecular Mechanisms of Hepatic Steatosis and Insulin Resistance in the AGPAT2-Deficient Mouse Model of Congenital Generalized Lipodystrophy
Victor A. Cortes et al.
CELL METABOLISM (2009)
Fatty Acid Synthase: Association with Insulin Resistance, Type 2 Diabetes, and Cancer
Javier A. Menendez et al.
CLINICAL CHEMISTRY (2009)
Butyrate Improves Insulin Sensitivity and Increases Energy Expenditure in Mice
Zhanguo Gao et al.
DIABETES (2009)
A Novel Pregnane X Receptor and S14-Mediated Lipogenic Pathway in Human Hepatocyte
Amelie Moreau et al.
HEPATOLOGY (2009)
Roles of adipose restriction and metabolic factors in progression of steatosis to steatohepatitis in obese, diabetic mice
Claire Z. Larter et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2009)
SIRT1 Knockout Leads to Angiogenesis Deficiency in Adipose Tissue through Macrophage Dysfunction
Fen Xu et al.
DIABETES (2009)
Overproduction of very low-density lipoproteins is the hallmark of the dyslipidemia in the metabolic syndrome
Martin Adiels et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2008)
Liver-specific deletion of histone deacetylase 3 disrupts metabolic transcriptional networks
Sarah K. Knutson et al.
EMBO JOURNAL (2008)
Hepatic fatty acid transporter Cd36 is a common target of LXR, PXR, and PPARγ in promoting steatosis
Jie Zhou et al.
GASTROENTEROLOGY (2008)
Aminotransferase Levels and 20-Year Risk of Metabolic Syndrome, Diabetes, and Cardiovascular Disease
Wolfram Goessling et al.
GASTROENTEROLOGY (2008)
Sudden Cardiac Death in Association With the Ketogenic Diet
Ilana M. Bank et al.
PEDIATRIC NEUROLOGY (2008)
Non-alcoholic fatty liver disease and the metabolic syndrome: An update
R. Scott Rector et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2008)
Intrahepatic fat accumulation and alterations in lipoprotein composition in obese adolescents
Anna M. G. Cali et al.
DIABETES CARE (2007)
Suppression of diacylglycerol acyltransferase-2 (DGAT2), but not DGAT1, with antisense oligonucleotides reverses diet-induced hepatic steatosis and insulin resistance
Cheol Soo Choi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Gestational diabetes: A review of the current literature and guidelines
Martine H. Hollander et al.
OBSTETRICAL & GYNECOLOGICAL SURVEY (2007)
Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis
Kanji Yamaguchi et al.
HEPATOLOGY (2007)
Review: The role of insulin resistance in nonalcoholic fatty liver disease
Kristina M. Utzschneider et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Liver-specific inhibition of ChREBP improves hepatic steatosis and insulin resistance in ob/ob mice
Renaud Dentin et al.
DIABETES (2006)
Mechanisms of β-cell death in type 2 diabetes
MY Donath et al.
DIABETES (2005)
Antisense oligonucleotide reduction of DGAT2 expression improves hepatic steatosis and hyperlipidemia in obese mice
XX Yu et al.
HEPATOLOGY (2005)
Type 1 diabetes: recent developments
D Devendra et al.
BMJ-BRITISH MEDICAL JOURNAL (2004)
Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma
HB El-Serag et al.
GASTROENTEROLOGY (2004)
Molecular mediators of hepatic steatosis and liver injury
JD Browning et al.
JOURNAL OF CLINICAL INVESTIGATION (2004)
Combined analysis of oligonucleotide microarray data from transgenic and knockout mice identifies direct SREBP target genes
JD Horton et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Nonalcoholic steatohepatitis: Summary of an AASLD Single Topic Conference
BA Neuschwander-Tetri et al.
HEPATOLOGY (2003)
Regulation of microsomal triglyceride transfer protein gene by insulin in HepG2 cells -: Roles of MAPKerk and MAPKp38
WS Au et al.
DIABETES (2003)
Antidiabetic action of a liver X receptor agonist mediated by inhibition of hepatic gluconeogenesis
GQ Cao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
The liver X receptor gene team: Potential new players in atherosclerosis
JJ Repa et al.
NATURE MEDICINE (2002)
Liver pyruvate kinase polymorphisms are associated with type 2 diabetes in northern European Caucasians
H Wang et al.
DIABETES (2002)
Fasting and postprandial overproduction of intestinally derived lipoproteins in an animal model of insulin resistance -: Evidence that chronic fructose feeding in the hamster is accompanied by enhanced intestinal de novo lipogenesis and ApoB48-containing lipoprotein overproduction
M Haidari et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Absence of sterol regulatory element-binding protein-1 (SREBP-1) ameliorates fatty livers but not obesity or insulin resistance in Lepob/Lepob mice
N Yahagi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Nonalcoholic fatty liver disease - A feature of the metabolic syndrome
G Marchesini et al.
DIABETES (2001)
A glucose-responsive transcription factor that regulates carbohydrate metabolism in the liver
H Yamashita et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Very-low-density lipoprotein assembly and secretion
GS Shelness et al.
CURRENT OPINION IN LIPIDOLOGY (2001)
Nonalcoholic steatohepatitis: Association of insulin resistance and mitochondrial abnormalities
AJ Sanyal et al.
GASTROENTEROLOGY (2001)
分享论文
